Walead Ebrahimizadeh

533 total citations
26 papers, 453 citations indexed

About

Walead Ebrahimizadeh is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Walead Ebrahimizadeh has authored 26 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Immunology. Recurrent topics in Walead Ebrahimizadeh's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (9 papers) and Immunotherapy and Immune Responses (5 papers). Walead Ebrahimizadeh is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (9 papers) and Immunotherapy and Immune Responses (5 papers). Walead Ebrahimizadeh collaborates with scholars based in Iran, Canada and United States. Walead Ebrahimizadeh's co-authors include Masoumeh Rajabibazl, Seyed Latif Mousavi Gargari, Iraj Rasooli, Hamid Bakherad, Hamed Zare, Mohammadali Mohammadi, Mohammad Mohammadi, Zahra Payandeh, Milad Bastami and Zargham Sepehrizadeh and has published in prestigious journals such as Clinical Cancer Research, British Journal of Cancer and Applied Microbiology and Biotechnology.

In The Last Decade

Walead Ebrahimizadeh

25 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Walead Ebrahimizadeh Iran 13 266 258 111 97 44 26 453
Irēna Meistere Latvia 11 166 0.6× 71 0.3× 83 0.7× 29 0.3× 38 0.9× 15 367
Jonas Kügler Germany 12 265 1.0× 246 1.0× 75 0.7× 74 0.8× 48 1.1× 17 436
Michael J. Shields United States 15 246 0.9× 82 0.3× 213 1.9× 37 0.4× 29 0.7× 24 483
Anand Kumar India 11 174 0.7× 65 0.3× 139 1.3× 29 0.3× 34 0.8× 20 388
Tuomas Huovinen Finland 11 391 1.5× 146 0.6× 41 0.4× 54 0.6× 39 0.9× 23 576
Cedric Ververken Belgium 7 144 0.5× 125 0.5× 98 0.9× 13 0.1× 39 0.9× 9 332
Philip Hobson United Kingdom 9 124 0.5× 81 0.3× 160 1.4× 34 0.4× 46 1.0× 13 365
John Swindle United States 17 438 1.6× 68 0.3× 168 1.5× 43 0.4× 47 1.1× 34 772
Leslie S. Casey United States 8 226 0.8× 51 0.2× 137 1.2× 42 0.4× 21 0.5× 10 387
Lauren Whitehead United Kingdom 3 236 0.9× 32 0.1× 335 3.0× 35 0.4× 34 0.8× 3 560

Countries citing papers authored by Walead Ebrahimizadeh

Since Specialization
Citations

This map shows the geographic impact of Walead Ebrahimizadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walead Ebrahimizadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walead Ebrahimizadeh more than expected).

Fields of papers citing papers by Walead Ebrahimizadeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walead Ebrahimizadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walead Ebrahimizadeh. The network helps show where Walead Ebrahimizadeh may publish in the future.

Co-authorship network of co-authors of Walead Ebrahimizadeh

This figure shows the co-authorship network connecting the top 25 collaborators of Walead Ebrahimizadeh. A scholar is included among the top collaborators of Walead Ebrahimizadeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walead Ebrahimizadeh. Walead Ebrahimizadeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zare, Hamed, et al.. (2024). Investigating the effect of cGRP78 vaccine against different cancer cells and its role in reducing melanoma metastasis. Research in Pharmaceutical Sciences. 19(1). 73–82. 1 indexed citations
2.
Dorigo, Oliver, Amit M. Oza, Tanja Pejović, et al.. (2023). Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial. Clinical Cancer Research. 29(15). 2808–2815. 7 indexed citations
3.
Zare, Hamed, et al.. (2023). Introduction of a new recombinant vaccine based on GRP78 for breast cancer immunotherapy and evaluation in a mouse model. Bioimpacts. 14(2). 27829–27829. 5 indexed citations
4.
Ebrahimizadeh, Walead, Karl‐Philippe Guérard, Eleonora Scarlata, et al.. (2023). A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients. British Journal of Cancer. 128(12). 2165–2174. 1 indexed citations
5.
Dorigo, Oliver, Walead Ebrahimizadeh, Lisa D. MacDonald, et al.. (2021). 353 Identification of potential response predictors to maveropepimut-S (DPX-Survivac), a novel T cell activating immunotherapy, in patients with advanced recurrent ovarian cancer. Regular and Young Investigator Award Abstracts. A380–A380. 1 indexed citations
6.
Ebrahimizadeh, Walead, Karl‐Philippe Guérard, Eleonora Scarlata, et al.. (2020). Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification–Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples. Journal of Molecular Diagnostics. 22(10). 1246–1263. 5 indexed citations
7.
Bakherad, Hamid, Seyed Latif Mousavi Gargari, Zargham Sepehrizadeh, et al.. (2017). Identification and in vitro characterization of novel nanobodies against human granulocyte colony-stimulating factor receptor to provide inhibition of G-CSF function. Biomedicine & Pharmacotherapy. 93. 245–254. 15 indexed citations
8.
Malekshahi, Ziba Veisi, Masoumeh Rajabibazl, Walead Ebrahimizadeh, Jafar Amani, & Babak Negahdari. (2017). Designing a Chimeric Vaccine Against Colorectal Cancer. International Journal of Cancer Management. 10(12).
9.
Gargari, Seyed Latif Mousavi, et al.. (2017). Targeting Colorectal Cancer Cell Lines Using Nanobodies; AgSK1as a Potential Target. Iranian Journal of Biotechnology. 15(2). 78–86. 8 indexed citations
10.
Rasooli, Iraj, et al.. (2015). Immunogenicity of conserved cork and β-barrel domains of baumannii acinetobactin utilization protein in an animal model. TURKISH JOURNAL OF MEDICAL SCIENCES. 45(6). 1396–1402. 13 indexed citations
11.
Payandeh, Zahra, et al.. (2014). Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii. Transactions of the Royal Society of Tropical Medicine and Hygiene. 108(2). 92–98. 26 indexed citations
12.
Zare‐Abdollahi, Davood, Saeid Safari, Reza Mirfakhraie, et al.. (2014). Mutational screening of theNR5A1in azoospermia. Andrologia. 47(4). 395–401. 15 indexed citations
13.
Rajabibazl, Masoumeh, et al.. (2014). Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF. Microvascular Research. 97. 13–18. 12 indexed citations
14.
Rasooli, Iraj, et al.. (2014). A conserved region from biofilm associated protein as a biomarker for detection of Acinetobacter baumannii. Microbial Pathogenesis. 77. 84–88. 3 indexed citations
15.
Ebrahimizadeh, Walead & Masoumeh Rajabibazl. (2014). Bacteriophage Vehicles for Phage Display: Biology, Mechanism, and Application. Current Microbiology. 69(2). 109–120. 54 indexed citations
16.
Bakherad, Hamid, Seyed Latif Mousavi Gargari, Iraj Rasooli, et al.. (2013). In Vivo Neutralization of Botulinum Neurotoxins Serotype E with Heavy-chain Camelid Antibodies (VHH). Molecular Biotechnology. 55(2). 159–167. 44 indexed citations
17.
Ebrahimizadeh, Walead, et al.. (2013). A novel VHH nanobody against the active site (the CA domain) of tumor-associated, carbonic anhydrase isoform IX and its usefulness for cancer diagnosis. Biotechnology Letters. 36(1). 21–28. 26 indexed citations
18.
Gargari, Seyed Latif Mousavi, Iraj Rasooli, Mohammadali Mohammadi, et al.. (2013). A novel nanobody against urease activity of Helicobacter pylori. International Journal of Infectious Diseases. 17(9). e723–e728. 44 indexed citations
19.
Gargari, Seyed Latif Mousavi, et al.. (2012). Inhibition of H. pylori colonization and prevention of gastritis in murine model. World Journal of Microbiology and Biotechnology. 28(7). 2513–2519. 3 indexed citations
20.
Gargari, Seyed Latif Mousavi, et al.. (2011). Treatment of Helicobacter pylori infection in mice with oral administration of egg yolk-driven anti-UreC immunoglobulin. Microbial Pathogenesis. 51(5). 366–372. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irēna Meistere Breakdown of academic impact, for papers by Jonas Kügler Breakdown of academic impact, for papers by Michael J. Shields Breakdown of academic impact, for papers by Anand Kumar Breakdown of academic impact, for papers by Tuomas Huovinen Breakdown of academic impact, for papers by Cedric Ververken Breakdown of academic impact, for papers by Philip Hobson Breakdown of academic impact, for papers by John Swindle Breakdown of academic impact, for papers by Leslie S. Casey Breakdown of academic impact, for papers by Lauren Whitehead
Rankless by CCL
2026